Relationship of Linezolid Minimum Inhibitory Concentration and Time to Bacterial Eradication in Treatment for Methicillin-Resistant Staphylococcus Aureus Infection

Abstract

Get full access to this article

View all access options for this article.

References

Kelly

, Collins

, Davin

, Gowing

, Murphy

. Linezolid resistance in coagulase negative staphylococci. J Antimicrob Chemother 2006; 58: 898-9; author reply 899-900.

Steinkraus

, White

, Friedrich

. Vancomycin MIC creep in non–vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001–05. J Antimicrob Chemother 2007; 60: 788-94.

Andes

, van Ogtrop

, Peng

. Craig

. In vivo pharmacodynamics of a new oxazolidinone (linezolid). Antimicrob Agents Chemother 2002; 46: 3484-9.

Gee

, Ellis

, Marshall

, et al. Pharmacokinetics and tissue penetration of linezolid following multiple oral doses. Antimicrob Agents Chemother 2001; 45: 1843-6.

Moise

, Forrest

, Birmingham

, Schentag

. The efficacy and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin. J Antimicrob Chemother 2002; 50: 1017-26.